Melatonin intervention to prevent nanomaterial exposure‐induced damages: A systematic review and meta‐analysis of in vitro and in vivo studies
Abstract
Given its antioxidant, anti‐inflammatory, and antiapoptotic properties, melatonin (MEL), a health‐caring food to improve sleep disorders, is hypothesized to protect against nanomaterial exposure‐induced toxicity. However, the conclusion derived from different studies seemed inconsistent. A meta‐analysis of all available preclinical studies was performed to examine the effects of MEL on nanomaterial‐induced damages. Eighteen relevant studies were retrieved through searching five electronic databases up to December 2023. The meta‐analysis showed that relative to control, MEL treatment significantly increased cell viability (standardized mean difference [SMD = 1.27]) and alleviated liver function (lowered AST [SMD = −3.89] and ALT [SMD = −5.89]), bone formation (enhanced BV/TV [SMD = 4.13] and lessened eroded bone surface [SMD = −5.40]), and brain nerve (inhibition of AChE activity [SMD = −3.60]) damages in animals. The protective mechanisms of MEL against damages caused by nanomaterial exposure were associated with its antiapoptotic (decreased Bax/Bcl‐2 ratio [SMD = −4.50] and caspase‐3 levels [dose <100 μM: SMD = −3.66]), antioxidant (decreased MDA [in vitro: SMD = −2.84; in vivo: SMD = −4.27]), and anti‐inflammatory (downregulated TNF‐α [in vitro: SMD = −5.41; in vivo: SMD = −3.21] and IL‐6 [in vitro: SMD = −5.90; in vivo: SMD = −2.81]) capabilities. In conclusion, our study suggests that MEL should be supplemented to prevent damages in populations exposed to nanomaterials.
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in animal and cell cultures (in vitro), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Evaluating the Evidence Base of Melatonin, Light Exposure, Exercise, and Complementary and Alternative Medicine for Patients with Insomnia Disorder
- Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis
- Influence of evening light exposure on polysomnographically assessed night-time sleep: A systematic review with meta-analysis
- Use of melatonin in children and adolescents with idiopathic chronic insomnia: a systematic review, meta-analysis, and clinical recommendation
- Significant potential of melatonin therapy in Parkinson’s disease – a meta-analysis of randomized controlled trials
- Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.